ES2113882T3 - Vacuna oral que comprende un antigeno asociado superficialmente con eritrocitos. - Google Patents
Vacuna oral que comprende un antigeno asociado superficialmente con eritrocitos.Info
- Publication number
- ES2113882T3 ES2113882T3 ES91908727T ES91908727T ES2113882T3 ES 2113882 T3 ES2113882 T3 ES 2113882T3 ES 91908727 T ES91908727 T ES 91908727T ES 91908727 T ES91908727 T ES 91908727T ES 2113882 T3 ES2113882 T3 ES 2113882T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- erythrocytes
- antigen associated
- associated surface
- date oct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6006—Cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
LAS CELULAS ROJAS DE LA SANGRE O LOS DERIVADOS DE LAS MISMAS PUEDEN ACTUAR COMO PORTADORES POTENTES PARA ANTIGENOS ORALMENTE ADMINISTRADOS. EN PARTICULAR, PUEDE INDUCIRSE DE MANERA EFECTIVA LA INMUNIDAD DE LAS MUCOSAS CONTRA VIRUS COMO EL "INFLUENZA" CUANDO SE ENCUENTRA ABSORBIDO EN CELULAS ROJAS DE LA SANGRE DE POLLOS Y SE ADMINISTRA ORALMENTE.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPJ978390 | 1990-04-24 | ||
PCT/AU1991/000159 WO1991016073A1 (en) | 1990-04-24 | 1991-04-24 | Oral vaccine comprising antigen surface-associated with red blood cells |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2113882T3 true ES2113882T3 (es) | 1998-05-16 |
Family
ID=3774614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91908727T Expired - Lifetime ES2113882T3 (es) | 1990-04-24 | 1991-04-24 | Vacuna oral que comprende un antigeno asociado superficialmente con eritrocitos. |
Country Status (15)
Country | Link |
---|---|
US (1) | US5643577A (es) |
EP (1) | EP0528859B1 (es) |
JP (1) | JPH05506233A (es) |
KR (1) | KR100186783B1 (es) |
AT (1) | ATE162402T1 (es) |
AU (1) | AU646257B2 (es) |
BR (1) | BR9106374A (es) |
CA (1) | CA2080477A1 (es) |
DE (1) | DE69128782T2 (es) |
DK (1) | DK0528859T3 (es) |
ES (1) | ES2113882T3 (es) |
GR (1) | GR3026569T3 (es) |
HK (1) | HK1004060A1 (es) |
SG (1) | SG46225A1 (es) |
WO (1) | WO1991016073A1 (es) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5882649A (en) * | 1990-04-24 | 1999-03-16 | Flustat Pty. Ltd. | Oral vaccine comprising antigen surface-associated with red blood cells |
GB2294268A (en) | 1994-07-07 | 1996-04-24 | Procter & Gamble | Bleaching composition for dishwasher use |
GB9517269D0 (en) * | 1995-08-23 | 1995-10-25 | Cortecs Ltd | Vaccines |
US5993852A (en) * | 1997-08-29 | 1999-11-30 | Pharmaderm Laboratories Ltd. | Biphasic lipid vesicle composition for transdermal administration of an immunogen |
CA2310457A1 (en) | 1997-11-21 | 1999-06-03 | Laura Anne Oakes | Product applicator |
GB2369094A (en) | 2000-11-17 | 2002-05-22 | Procter & Gamble | Packaging assembly for sheets of water-soluble sachets |
WO2002060416A1 (en) * | 2001-02-01 | 2002-08-08 | Gendel Limited | Polypeptide delivery system and method for their preparation |
US20060083702A1 (en) * | 2004-04-02 | 2006-04-20 | Thomas Fondin | Hair fiber treating method |
JP4455591B2 (ja) | 2004-12-22 | 2010-04-21 | 富士フイルム株式会社 | ω−アルコキシペルオキシカルボン酸を含有する殺菌用組成物 |
WO2007150020A1 (en) * | 2006-06-23 | 2007-12-27 | Simon Paul M | Targeted immune conjugates |
US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
US8680020B2 (en) | 2008-07-15 | 2014-03-25 | Academia Sinica | Glycan arrays on PTFE-like aluminum coated glass slides and related methods |
GB0901207D0 (en) | 2009-01-26 | 2009-03-11 | Innospec Ltd | Chelating agents and methods relating thereto |
US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
WO2011130332A1 (en) | 2010-04-12 | 2011-10-20 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
WO2011138032A2 (en) | 2010-05-05 | 2011-11-10 | Artemev, Timur | Universal influenza vaccines and methods for their generation |
AR083533A1 (es) | 2010-10-22 | 2013-03-06 | Boehringer Ingelheim Vetmed | Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe |
WO2012059112A1 (en) * | 2010-11-01 | 2012-05-10 | Mahmoud Abdel Wahed Rafea | Development of medical products based on a new discovered function of red blood cells |
ES2685333T3 (es) * | 2011-06-02 | 2018-10-08 | The Regents Of The University Of California | Nanopartículas encapsuladas en membrana y método de utilización |
AR088028A1 (es) | 2011-08-15 | 2014-05-07 | Boehringer Ingelheim Vetmed | Proteinas h5, de h5n1 para un uso medicinal |
ES2764105T3 (es) | 2011-10-17 | 2020-06-02 | Massachusetts Inst Technology | Administración intracelular |
US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
CA2880701A1 (en) | 2012-08-18 | 2014-02-27 | Academia Sinica | Cell-permeable probes for identification and imaging of sialidases |
EP2958586B1 (en) | 2013-02-21 | 2018-09-05 | Boehringer Ingelheim Vetmedica GmbH | H5 proteins of h5n1 influenza virus for use as a medicament |
US10086054B2 (en) | 2013-06-26 | 2018-10-02 | Academia Sinica | RM2 antigens and use thereof |
US9981030B2 (en) | 2013-06-27 | 2018-05-29 | Academia Sinica | Glycan conjugates and use thereof |
AU2014306423B2 (en) | 2013-08-16 | 2019-04-18 | Massachusetts Institute Of Technology | Selective delivery of material to cells |
KR102298172B1 (ko) | 2013-09-06 | 2021-09-06 | 아카데미아 시니카 | 변화된 글리코실 그룹을 갖는 당지질을 사용한 인간 iNKT 세포 활성화 |
WO2015109180A2 (en) | 2014-01-16 | 2015-07-23 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
EP3129767B1 (en) | 2014-03-27 | 2021-09-01 | Academia Sinica | Reactive labelling compounds and uses thereof |
CN107074945B (zh) | 2014-05-27 | 2021-08-24 | 中央研究院 | 增进抗体功效的通用糖型的组合物及方法 |
WO2015184002A1 (en) | 2014-05-27 | 2015-12-03 | Academia Sinica | Anti-her2 glycoantibodies and uses thereof |
US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
CA2950415A1 (en) | 2014-05-27 | 2015-12-03 | Academia Sinica | Anti-cd20 glycoantibodies and uses thereof |
WO2015184001A1 (en) | 2014-05-28 | 2015-12-03 | Academia Sinica | Anti-tnf-alpha glycoantibodies and uses thereof |
WO2016040369A2 (en) | 2014-09-08 | 2016-03-17 | Academia Sinica | HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS |
SG11201703044PA (en) | 2014-10-31 | 2017-05-30 | Massachusetts Inst Technology | Delivery of biomolecules to immune cells |
CN107002089B (zh) | 2014-11-14 | 2021-09-07 | 麻省理工学院 | 化合物和组合物向细胞中的破坏和场实现的递送 |
WO2016115179A1 (en) | 2015-01-12 | 2016-07-21 | Massachusetts Institute Of Technology | Gene editing through microfluidic delivery |
US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
JP6779887B2 (ja) | 2015-01-24 | 2020-11-04 | アカデミア シニカAcademia Sinica | 新規なグリカンコンジュゲートおよびその使用方法 |
EP3320082B1 (en) | 2015-07-09 | 2023-05-24 | Massachusetts Institute of Technology | Delivery of materials to anucleate cells |
US11613759B2 (en) | 2015-09-04 | 2023-03-28 | Sqz Biotechnologies Company | Intracellular delivery of biomolecules to cells comprising a cell wall |
WO2017156192A1 (en) | 2016-03-08 | 2017-09-14 | Academia Sinica | Methods for modular synthesis of n-glycans and arrays thereof |
JP7213549B2 (ja) | 2016-08-22 | 2023-01-27 | シーエイチオー ファーマ インコーポレイテッド | 抗体、結合性断片、および使用の方法 |
GB2625450A (en) | 2022-12-16 | 2024-06-19 | Innospec Performance Chemicals Italia Srl | Compositions |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4136167A (en) * | 1975-06-12 | 1979-01-23 | Internationale Octrooi Maatschappij "Octropa" B.V. | Process for reducing the incidence of neonatal diarrhoea in pigs |
DE2551208C3 (de) * | 1975-11-14 | 1981-05-27 | Behringwerke Ag, 3550 Marburg | Verfahren zur Herstellung einer stabilen Erythrozyten-Präparation |
FR2355507A1 (fr) * | 1976-06-25 | 1978-01-20 | Inst Nat Sante Rech Med | Vaccin antiparasitaire par voie orale, son procede de preparation et sa methode d'application chez les mammiferes |
SU649435A1 (ru) * | 1977-06-24 | 1979-02-28 | Уфимский Научно-Исследовательский Институт Вакции И Сывороток Им. И.И.Мечникова | Способ приготовлени эритроцитов |
US4403037A (en) * | 1980-10-10 | 1983-09-06 | American Hoechst Corporation | Erythrocyte preparations and use thereof in hemagglutination tests |
US5075109A (en) * | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
US4904468A (en) * | 1987-06-08 | 1990-02-27 | Norden Laboratories, Inc. | Canine coronavirus vaccine |
-
1991
- 1991-04-24 EP EP91908727A patent/EP0528859B1/en not_active Expired - Lifetime
- 1991-04-24 JP JP91508089A patent/JPH05506233A/ja active Pending
- 1991-04-24 BR BR919106374A patent/BR9106374A/pt not_active Application Discontinuation
- 1991-04-24 KR KR1019920702617A patent/KR100186783B1/ko not_active IP Right Cessation
- 1991-04-24 WO PCT/AU1991/000159 patent/WO1991016073A1/en active IP Right Grant
- 1991-04-24 DK DK91908727T patent/DK0528859T3/da active
- 1991-04-24 DE DE69128782T patent/DE69128782T2/de not_active Expired - Fee Related
- 1991-04-24 AU AU77531/91A patent/AU646257B2/en not_active Ceased
- 1991-04-24 SG SG1996001205A patent/SG46225A1/en unknown
- 1991-04-24 CA CA002080477A patent/CA2080477A1/en not_active Abandoned
- 1991-04-24 ES ES91908727T patent/ES2113882T3/es not_active Expired - Lifetime
- 1991-04-24 AT AT91908727T patent/ATE162402T1/de not_active IP Right Cessation
- 1991-04-24 US US07/940,899 patent/US5643577A/en not_active Expired - Fee Related
-
1998
- 1998-04-07 GR GR980400760T patent/GR3026569T3/el unknown
- 1998-04-18 HK HK98103261A patent/HK1004060A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5643577A (en) | 1997-07-01 |
AU646257B2 (en) | 1994-02-17 |
DE69128782D1 (de) | 1998-02-26 |
JPH05506233A (ja) | 1993-09-16 |
GR3026569T3 (en) | 1998-07-31 |
BR9106374A (pt) | 1993-03-30 |
CA2080477A1 (en) | 1991-10-25 |
EP0528859B1 (en) | 1998-01-21 |
DE69128782T2 (de) | 1998-09-10 |
WO1991016073A1 (en) | 1991-10-31 |
EP0528859A1 (en) | 1993-03-03 |
AU7753191A (en) | 1991-11-11 |
SG46225A1 (en) | 1998-02-20 |
EP0528859A4 (en) | 1993-08-04 |
HK1004060A1 (en) | 1998-11-13 |
KR100186783B1 (ko) | 1999-05-01 |
DK0528859T3 (da) | 1998-09-14 |
ATE162402T1 (de) | 1998-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2113882T3 (es) | Vacuna oral que comprende un antigeno asociado superficialmente con eritrocitos. | |
ES2176232T3 (es) | Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter. | |
FI970799A (fi) | Mutanttientoroksiini, joka on tehokas ei-toksinen oraalinen adjuvantti | |
CO5210894A1 (es) | Composiciones adyudantes que comprenden una sal de aluminio y un inmunoestimulante | |
MX9304089A (es) | Uso de gm-csf como una vacuna adyuvante. | |
DE69425427D1 (de) | Ein pharmazeutisches präparat zur topischen verabreichung von antigenen und/oder vakzinen an die schleimhäute von säugern | |
ES2098029T3 (es) | Vacunas de hepatitis que contienen monofosforil lipido a 3-o-desacilado. | |
AU2684792A (en) | Porcine reproductive respiratory syndrome vaccine and diagnostic | |
DE69943170D1 (de) | Immunologische Zusammensetzung und Impfstoffe, die einen auf N-Formyl-Methionyl Peptide bestehenden Adjuvans enthalten | |
ES2075440T3 (es) | Vacuna contra la hepatitis b. | |
ES2044849T3 (es) | Un procedimiento para preparar un glicosido de flavona. | |
NO940661L (no) | Peptider for indusering av cytotoksisk T-lymfocytreaksjoner mot hepatit B virus | |
HUP9901958A2 (hu) | Sertés reproduktív és respirációs szindróma vakcina | |
GB1183506A (en) | New vaccines for combating influenza and the preparation thereof | |
CA2078605A1 (en) | Chicken anaemia agent vaccine | |
AU6383296A (en) | Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection | |
EP0090660A3 (en) | Neisseria gonorrhoeae vaccine | |
ATE18007T1 (de) | Hepatitisimpfstoff. | |
DK1416958T4 (da) | Vaccinesammensætning, som indeholder mindst to valenser, én med adjuvans og én uden adjuvans | |
AR012896A1 (es) | Polipeptido flge de helicobacter pylori, composicion de vacuna, uso de dicho polipeptido para la fabricacion de composiciones, metodo de diagnostico invitro, y kit de diagnostico para la deteccion de la infeccion por helicobacter pylori | |
Lionarons et al. | Five cases of reactive arthritis after an outbreak of Shigella flexneri infection in the Netherlands. | |
JPS5287221A (en) | Preventive for chicken dinfections | |
Schwab et al. | Reactions of monkeys to experimental respiratory infections. II. Response to streptococcus hemolyticus group c | |
WO2000012129A3 (en) | Salmonella typhi vaccine compositions | |
Tyroler | El Salvador: Death Squads Suspected In Recent Killings |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 528859 Country of ref document: ES |